Physician profile
Jonathan Bean
NPI 1356583413
$767.61
in general payments reported to CMS, 2019-2025
9 companies · $40.07 in 2025
The $40.07 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $34.75 · 2022: $140 · 2023: $387 · 2024: $64.74 · 2025: $40.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350 · Travel and Lodging: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.57 |
| Travel and Lodging | $142.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $223.23 | 2023 | Spyglass Discover |
| Zimmer Biomet Holdings, INC. | $157.82 | 2023-2025 | Ribfix Titan |
| W. L. Gore & Associates, INC. | $139.53 | 2022 | |
| Merck Sharp & Dohme LLC | $124.96 | 2019-2024 | Bridion |
| Ethicon US, LLC | $34.75 | 2020 | |
| Acera Surgical, INC. | $24.93 | 2024 | Restrata Wound Matrix |
| Organogenesis INC. | $24.75 | 2025 | Puraply Wound Matrix |
| Haemonetics Corporation | $21.53 | 2023 | Teg6s Hemostasis System |
| Polynovo North America LLC | $16.11 | 2024 | Novosorb Btm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Bean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.